UNSPSC 51123205: Pentisomide

This classification denotes an antiarrhythmic agent with the molecular formula C19H33N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 506T8KTW5Q, chemically known as 2-pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-(2-methylpropyl)-, (+-)- but more generally known as pentisomide, which bears US NIH Compound Identifier 65847. European Medicines Agency schedules Pentisomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09697MIG.

UNSPSC 51123205 Pentisomide is a Commodity code that covers advanced life support medications, including vasoactive agents and cardiac-supportive drugs used by emergency medical services and fire rescue operations. State and local governments use this code to procure sealed-bid supplies of prescription medications for EMS protocols, fire rescue paramedic teams, and hospital emergency departments. The City of Tampa's recent IFB for Advanced Life Support Medications (Bid No. 26-P-00188, due April 8, 2026) exemplifies the scope: the solicitation called for Labetalol, Epinephrine, Adenosine, and Diltiazem in specified unit quantities to support Tampa Fire Rescue paramedics in Hillsborough County, Florida. Issuing bodies include municipal fire departments and rescue services, which procure these medications through their purchasing departments. The solicitation requirements are typical of the code: vendors must meet expiration-date minimums (nine months at delivery), deliver within ten calendar days of order, warrant product integrity for 365 days, manage replacement of expired stock, and provide Safety Data Sheets compliant with OSHA Hazard Communication Standards. Pricing is firm, FOB destination, and inclusive of shipping and applicable taxes.

Recent activity concentrates in Florida, where the City of Tampa's municipal purchasing office has actively solicited under this code. The estimated contract value for Tampa's Advanced Life Support Medications IFB is $40,000.00, with a one-year term and two optional renewal periods plus up to three additional 30-day extensions. The procurement included a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount capped at $10,000 for SLBE participation. Bidders were required to submit electronic bids through OpenGov eProcurement and to provide accessibility documentation under WCAG 2.2 Level AA and Section 508 standards, reflecting the City's conformance requirements for medical procurement.